US-based biomedical technology company Setpoint Medical Corporation has raised $30m in a Series D financing round led by New Enterprise Associates .

The company plans to use the funds to advance the development of its bioelectronic therapy for inflammatory diseases.

Chinese company Zhuhai Hokai Medical Instruments Co Ltd plans to raise CNY1bn ($150.1m) through the public offering of convertible bonds due in 2023.

"The company plans to use the funds to advance the development of its bioelectronic therapy for inflammatory diseases."

US-based genomics research and diagnostics company MedGenome Inc has secured $30m in a Series C venture financing round led by Sequoia Capital India Advisors Pvt Ltd.

The company intends to use the stocks to progress its biomarker discovery programmes.